182 related articles for article (PubMed ID: 2969977)
1. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.
Loutzenhiser R; Hayashi K; Epstein M
J Pharmacol Exp Ther; 1988 Aug; 246(2):522-8. PubMed ID: 2969977
[TBL] [Abstract][Full Text] [Related]
2. Reversal by the calcium antagonist nisoldipine of norepinephrine-induced reduction of GFR: evidence for preferential antagonism of preglomerular vasoconstriction.
Loutzenhiser R; Epstein M; Horton C; Sonke P
J Pharmacol Exp Ther; 1985 Feb; 232(2):382-7. PubMed ID: 3968640
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney.
Marin-Grez M; Fleming JT; Steinhausen M
Nature; 1986 Dec 4-10; 324(6096):473-6. PubMed ID: 2946962
[TBL] [Abstract][Full Text] [Related]
4. Determinants of renal actions of atrial natriuretic peptide. Lack of effect of atrial natriuretic peptide on pressure-induced vasoconstriction.
Hayashi K; Epstein M; Loutzenhiser R
Circ Res; 1990 Jul; 67(1):1-10. PubMed ID: 2163775
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide and the kidney.
Ballermann BJ; Brenner BM
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):7-12. PubMed ID: 3037892
[TBL] [Abstract][Full Text] [Related]
6. Renal microvascular actions of calcium antagonists.
Loutzenhiser R; Epstein M
J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S3-12. PubMed ID: 16989072
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and pharmacodynamics of atrial natriuretic peptide and lithium clearance in the isolated perfused rat kidney.
Brier ME; Brier RA; Luft FC; Aronoff GR
J Pharmacol Exp Ther; 1987 Dec; 243(3):868-73. PubMed ID: 2961879
[TBL] [Abstract][Full Text] [Related]
8. Renal hemodynamic and natriuretic effects of atrial natriuretic factor.
Maack T; Atlas SA; Camargo MJ; Cogan MG
Fed Proc; 1986 Jun; 45(7):2128-32. PubMed ID: 3011521
[TBL] [Abstract][Full Text] [Related]
9. [Physiology and pathophysiology of renal circulation].
Steinhausen M
Z Kardiol; 1987; 76 Suppl 4():71-9. PubMed ID: 3442091
[TBL] [Abstract][Full Text] [Related]
10. Effects of atrial natriuretic peptide on renal arterioles: morphometric analysis using microvascular casts.
Kimura K; Hirata Y; Nanba S; Tojo A; Matsuoka H; Sugimoto T
Am J Physiol; 1990 Dec; 259(6 Pt 2):F936-44. PubMed ID: 2148057
[TBL] [Abstract][Full Text] [Related]
11. The effects of sodium orthovanadate, noradrenaline and angiotensin II on isolated perfused rat kidney glomerular-tuft diameter.
Corder CN; Pathak H; Kumar A; Wells A
Indian J Physiol Pharmacol; 1983; 27(3):193-9. PubMed ID: 6559748
[TBL] [Abstract][Full Text] [Related]
12. Video-microscopic assessment of the role of tissue angiotensin-converting enzyme in the control of the renal microcirculation.
ter Wee PM; Forster HG; Epstein M
J Pharmacol Exp Ther; 1997 Apr; 281(1):434-9. PubMed ID: 9103527
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase products and atrial natriuretic peptide modulate renal response to endothelin.
Perico N; Dadan J; Gabanelli M; Remuzzi G
J Pharmacol Exp Ther; 1990 Mar; 252(3):1213-20. PubMed ID: 2138667
[TBL] [Abstract][Full Text] [Related]
14. Altered renal microvascular response in Zucker obese rats.
Hayashi K; Kanda T; Homma K; Tokuyama H; Okubo K; Takamatsu I; Tatematsu S; Kumagai H; Saruta T
Metabolism; 2002 Dec; 51(12):1553-61. PubMed ID: 12489067
[TBL] [Abstract][Full Text] [Related]
15. Effects of atrial natriuretic peptide on endothelin-induced vasoconstriction and intracellular calcium mobilization.
Suzuki E; Hirata Y; Matsuoka H; Sugimoto T; Hayakawa H; Shin WS; Toyooka T; Sugimoto T
J Hypertens; 1991 Oct; 9(10):927-34. PubMed ID: 1658135
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of atrial natriuretic peptide after bolus and infusion administration in the isolated perfused rat kidney.
Brier ME; Harding GB
J Pharmacol Exp Ther; 1989 May; 249(2):372-7. PubMed ID: 2542527
[TBL] [Abstract][Full Text] [Related]
17. Effects of atriopeptin III on isolated rat afferent and efferent arterioles.
Lanese DM; Yuan BH; Falk SA; Conger JD
Am J Physiol; 1991 Dec; 261(6 Pt 2):F1102-9. PubMed ID: 1661082
[TBL] [Abstract][Full Text] [Related]
18. Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II.
Takenaka T; Suzuki H; Fujiwara K; Kanno Y; Ohno Y; Hayashi K; Nagahama T; Saruta T
J Clin Invest; 1997 Oct; 100(8):2107-14. PubMed ID: 9329977
[TBL] [Abstract][Full Text] [Related]
19. Direct vasodilatory action of atrial natriuretic factor on canine glomerular afferent arterioles.
Ohishi K; Hishida A; Honda N
Am J Physiol; 1988 Sep; 255(3 Pt 2):F415-20. PubMed ID: 2970796
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by diltiazem of pressure-induced afferent vasoconstriction in the isolated perfused rat kidney.
Loutzenhiser R; Epstein M; Horton C
Am J Cardiol; 1987 Jan; 59(2):72A-75A. PubMed ID: 3812264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
